#clinical trials — iPharmag

Illustration of prediction markets on clinical trial outcomes

Business

You Can Now Bet on Clinical Trial Outcomes — and Pharma Insiders Are Worried

Prediction-market firm Kalshi has opened contracts on whether drugs will hit their endpoints or win FDA approval, raising fresh insider-trading and ethics concerns.

1 hr ago · 2 min read

Illustration of Agios halting its sickle cell drug tebapivat

R&D

Agios Scraps Sickle Cell Drug Tebapivat After Mid-Stage Disappointment

The company said its next-generation pyruvate kinase activator failed to show enough differentiation, ceding ground to a rival Novo Nordisk therapy.

1 hr ago · 2 min read

Illustration of Crystalys gout drug dotinurad targeting uric acid

R&D

Crystalys Raises $130M to Advance Its Gout Drug Through Late-Stage Trials

The Series B will fund Phase 2 and Phase 3 studies of dotinurad, a uric-acid-lowering therapy already approved in several Asian markets.

10 hr ago · 2 min read